Minor histocompatibility antigens

Current Opinion in Immunology

Volumn 9, Issue 5, 1997, Pages 655-661

  Simpson, Elizabeth ^a   Roopenian, Derry ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HY ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN; TRANSPLANTATION ANTIGEN;

GRAFT REJECTION; HISTOCOMPATIBILITY GENE; IMMUNOGENETICS; MINOR HISTOCOMPATIBILITY COMPLEX; REVIEW;

EID: 0030658864     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(97)80045-3     Document Type: Article

References (66)

1. Snell GD. Methods for the study of histocompatibility genes. J Genet. 49:1948;87-103.
2. Snell GD, Stimpfling JH. The genetics of transplantation. Green EL. Biology of the Laboratory Mouse. 1966;457-491 McGraw Hill Book Company, New York.
3. Bailey DW. Genetics of histocompatibility in mice I. New loci and congenic lines. Immunogenetics. 2:1975;249-256.
4. Ceppellini R, Mattiuz PL, Scudeller G, Visetti M. Experimental allotransplantation in man I. The role of the HLA system in different genetic combinations. Transplant Proc. 1:1969;385-389.
5. *A1) and then scored for graft-versus-host disease severity. There was found to be a correlation between disparity at HA-1 and more severe graft-versus-host disease.
6. Candinas D, Gunson BK, Nightingale P, Hubscher S, McMaster P, Neuberger JM. Sex mismatch as a risk factor for chronic rejection of liver allografts. Lancet. 346:1995;1117-1121.
7. Townsend ARM, Rothbard J, Gotch FM, Bahadur G, Wraith D, McMichael AJ. The epitopes of influenza nucleoprotein recognised by cytotoxic T lymphocytes can be defined by short synthetic peptides. Cell. 44:1986;959-968.
8. Rötzschke O, Falk K, Wallny HJ, Faath S, Rammensee HG. Characterisation of naturally occurring minor H peptides including H-4 and H-Y. Science. 249:1990;283-287.
9. Wallny H-J, Rammensee HG. Identification of classical minor histocompatibility antigen as cell-derived peptide. Nature. 343:1990;275-278.
10. Falk K, Rötzschke O, Stevanovic S, Jung G, Rammensee HG. Allele specific motifs revealed by sequencing of self peptides eluted from MHC molecules. Nature. 351:1991;290-296.
11. Loveland BE, Wang CR, Yonekawa H, Hermel E, Fischer Lindahl K. Maternally transmitted histocompatibility antigen of mice: a hydrophobic peptide of a mitochondrially encoded protein. Cell. 60:1990;971-980.
12. Gordon RD, Simpson E, Samelson LE. In vitro cell-mediated immune responses to the male-specific (H-Y) antigen in mice. J Exp Med. 142:1975;1108-1120.
13. Bevan MJ. The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens. J Exp Med. 142:1975;1349-1364.
14. Zinkemagel RM, Doherty PC. Restriction of in vitro mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semi-allogeneic system. Nature. 248:1974;701-702.
15. Hurme M, Chandler PR, Hetherington CM, Simpson E. Cytotoxic T cell responses to H-Y: correlation with the rejection of syngeneic male skin grafts. J Exp Med. 147:1978;768-775.
16. von Boehmer H, Haas W. Distinct Ir genes for helper and killer cells in the cytotoxic response to H-Y antigen. J Exp Med. 150:1979;1134-1142.
17. Simpson E. The role of H-Y as a minor transplantation antigen. Immunol Today. 3:1982;97-106.
18. + helper cells. J Immunol. 141:1988;391-397.
19. Roopenian DC, Davis AP, Christianson GJ, Mobraaten LE. The functional basis of minor histocompatibility loci. J Immunol. 151:1993;4595-4605.
20. Roopenian DC, Davis AP. Responses against antigens encoded by the H-3 histocompatibility locus: antigens stimulating class I MHC- and class II MHC-restricted T cells are encoded by separate genes. Immunogenetics. 30:1989;335-343.
21. Davis AP, Roopenian DC. Complexity at the mouse minor histocompatibility locus H-4. Immunogenetics. 31:1990;7-12.
22. Scott D, McLaren A, Dyson PJ, Simpson E. Variable spread of X inactivation affecting the expression of different epitopes of the Hya gene product in mouse B cell clones. Immunogenetics. 33:1991;54-61.
23. King TR, Christianson GJ, Mitchell MJ, Bishop C, Scott D, Ehrmann I, Simpson E, Eicher EM, Roopenian DC. Deletion mapping using immunoselection for H-Y further resolves the Sxr region of the mouse Y chromosome and reveals complexity at the Hya locus. Genomics. 24:1994;159-168.
24. Roopenian DC. What are minor histocompatibility loci? A new look to an old question. Immunol Today. 13:1992;7-10.
25. Turner JP, Carpentino JE, Cantwell AM, Hildebrandt AL, Myrie KA, King TR. Molecular genetic mapping of the mouse male sterility and histoincompatibility (mshl) mutation on proximal chromosome 10. Genomics. 39:1997;1-7.
26. Wettstein PJ. Immunodominance in the T cell response to multiple non H-Y histocompatibility antigens. II. Observation of a hierarchy among dominant antigens. Immunogenetics. 24:1986;24-31.
27. Yin L, Poirier G, Neth O, Hsuan JJ, Totty NF, Stauss HJ. Few peptides dominate CTL responses to single and multiple minor histocompatibility antigens. Int Immunol. 5:1993;1003-1009.
28. Wolpert E, Franksson L, Kärre K. Dominant and cryptic antigens in the MHC class I restricted T cell response across a complex minor histocompatibility barrier: analysis and mapping by elution of cellular peptides. Int Immunol. 7:1995;919-928.
29. Brenan M, Simpson E, Mullbacher A. Analysis of haplotype preference in the cytotoxic T cell response to H-Y. Immunogenetics. 13:1981;133-146.
30. Nevala WK, Wettstein PJ. The preferential cytolytic T lymphocyte response to immunodominant minor histocompatibility antigen peptides. of special interest Transplantation. 62:1996;283-291 Similar to Wolpert [28], which provides a thorough analysis of immunodominance from the view of eluted MHC-bound peptides and minor H congenic mouse strains and shows that dominated peptides are present in acid extracts, this paper also addresses the strain distribution of minor H antigens and shows that dominant minor H peptides in a complex mixture of minor H antigens competes better than dominated peptides.
31. Pion S, Fontaine P, Desaulniers M, Jutras J, Filep JG, Perreault C. On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens. of special interest Eur J Immunol. 27:1997;421-430 The first study to tackle the question of immunodominance using a defined immunodominant minor H antigen peptide. It shows that the cytotoxic T lymphocyte precursor frequency does not explain immunodominance, and that the immunodominant peptide binds avidly to its MHC protein.
32. Perreault C, Jutras J, Roy DC, Filep JG, Brochu S. Identification of an immunodominant mouse minor histocompatibility antigen (MiHA): T cell response to a single dominant MiHA causes graft-versus-host disease. of outstanding interest J Clin Invest. 98:1996;622-628 Describes the first dominant mouse minor H peptide to be sequenced. Immunisation with this peptide induces cytotoxic T lymphocyte activity and adoptive transfer of peptide-primed cells into irradiated recipient mice induces dermal lesions characteristic of graft-versus-host disease.
33. b (see [43] for the first) is identified as being encoded by a novel gene, Uty, at a sequence divergent from that of Utx. The approach used for the identification involved the transfection of a cDNA that had been mapped to the Sxrb deletion interval. The study established that the genetic complexity of Hya is due to more than a single gene.
34. Nevala WK, Paul C, Wettstein PJ. Reduced diversity of CTLs specific for multiple minor histocompatibility antigens relative to allograft rejection in vivo. J Immunol. 158:1997;1102-1107.
35. Morse M-C, Bleau G, Dabhi VM, Hetu F, Drobetsky EA, Fisher Lindahl K, Perreault C. The COI mitochondrial gene encodes a minor histocompatibility antigen presented by H2-M3. J Immunol. 156:1996;3301-3307.
36. Wang CR, Castano AR, Peterson PA, Slaughter C, Fisher Lindahl K, Deisenhofer J. Non-classical binding of formylated peptide in crystal structure of the MHC class Ib molecule H2-M3. Cell. 82:1995;655-664.
37. b. Immunogenetics. 45:1996;65-68.
38. Bhuyan PK, Young LL, Fisher Lindahl K, Butcher GW. Identification of the rat maternally transmitted minor histocompatibility antigen. of special interest J Immunol. 158:1997;3753-3760 Identifies the first rat mitochondrially-encoded minor H antigen. Along with [36], this paper shows that mitochondrial peptides can be presented by both MHC class Ia, RT1.A, and class Ib, H-2M3, molecules.
39. Simpson E, Scott D, Chandler P. The male-specific histocompatibility antigen, H-Y: a history of transplantation, immune response genes, sex determination and expression cloning. of special interest Annu Rev Immunol. 15:1997;39-61 Review detailing the history of male specific antigens from their discovery in vivo to their molecular characterization.
40. McLaren A, Simpson E, Tomonari K, Chandler P, Hogg H. Male sexual differentiation in mice lacking H-Y antigen. Nature. 312:1984;552-555.
41. McLaren A, Simpson E, Epplen JT, Studer R, Koopman P, Evans EP, Burgoyne PS. Location of the genes controlling H-Y antigen expression and testis determination on the mouse Y chromosome. Proc Natl Acad Sci USA. 85:1988;6442-6445.
42. Simpson EM, Page DC. An interstitial deletion in mouse Y chromosomal DNA created a transcribed Zfy fusion gene. Genomics. 11:1991;601-608.
43. Scott DM, Ehrmann IE, Ellis PS, Bishop CE, Agulnik AI, Simpson E, Mitchell MJ. Identification of a mouse male-specific transplantation antigen, H-Y. Nature. 376:1995;695-698.
44. Wang W, Meadows LR, den Haan JMM, Sherman NE, Chen Y, Blokland E, Shabanowitz J, Agulnik AI, Hendrickson RC, Bishop CE, et al. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science. 269:1995;1588-1590.
45. Simmons WA, Summerfield SG, Roopenian DC, Slaughter CA, Zuberi AR, Gaskell SJ, Bordoli RS, Hoyes J, Moomaw CR, Colbert RA, et al. Novel H-Y antigen peptides presented by HLA-B27. of special interest J Immunol. 1997; This work exploits state-of-the-art mass spectometric techniques to identify two novel H-Y peptides presented by HLA-B27 in both transgenic mice and rats. It shows that the same H-Y peptides can be detected in different species (rats and mice) provided that the species have the same MHC proteins.
46. *A0201 restricted but modified post-translationally by the addition of a cysteine residue. It is thus an example of how epigenetic mechanisms can alter the functional ligand.
47. Den Haan JMM, Sherman NE, Blokland E, Huczko E, Koning F, Drijfhout JW, Skipper J, Shabanowitz J, Hunt DF, Engelhard VH, Goulmy E. Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science. 268:1995;1476-1480.
48. Speiser DE, Zurcher T, Ramseier H, Hengartner H, Staeheli P, Haller O, Zinkernagel RM. Nuclear myxovirus-resistance protein Mx is a minor histocompatibility antigen. Proc Natl Acad Sci USA. 87:1990;2021-2025.
49. Kurtz ME, Martin-Morgan D, Graff RJ. Recognition of the β-2 microglobulin-B molecule by a CTL clone. J Immunol. 138:1987;87-90.
50. 2-microglobulin by cytotoxic T lymphocytes. Nature. 319:1986;502-504.
51. 2-microglobulin restriction of antigen presentation. Nature. 346:1990;751-754.
52. Gundlach BR, Wiesmuller KH, Junt T, Kienle S, Jung G, Walden P. Specificity and degeneracy of minor histocompatibility antigen-specific MHC-restricted CTL. J Immunol. 156:1996;3645-3651.
53. a recipients, implying that a CD8-specific epitope alone is not a transplantation antigen. A similar conclusion is implied with the P91A tumor specific transplantation antigen as a transgene [65].
54. Zuberi AR, Nguyen HQ, Auman HJ, Taylor BA, Roopenian DC. A genetic linkage map of mouse chromosome 2 extending from thrombospondin to paired box gene 1, including the H3 minor histocompatibility complex. of outstanding interest Genomics. 33:1996;75-84 Illustrates the positional cloning approach toward autosomal minor H loci and shows the considerable genetic complexity of the region encompassing the H3 complex.
55. b-restricted tumour antigen on EL4 cells.
56. +T cells can recognize unusual, rare and unique processed peptide/MHC complexes. J Immunol. 157:1996;4464-4473.
57. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature. 172:1953;603-606.
58. Starzl TE, Demetris AJ, Murase N, Trucco M, Thomson AW, Rao AS. The lost chord: microchimerism and allograft survival. of special interest Immunol Today. 17:1996;577-584 Report of operational tolerance in transplant patients no longer on immuno-suppressive drugs. Tolerance is ascribed to the microchimerism of the recipient, with donor cells of haematopoietic origin having migrated from the graft to the recipient. This phenomenon is well established but this interpretation controversial (compare with [60]).
59. van Rood JJ, Class FH. The influence of allogeneic cells on the human T and B cell repertoire. Science. 248:1990;1388-1393.
60. + T cells. Continuation of the tolerant state in the antibody-treated mice, however, is dependent on the presence of the alloantigen expessing graft. This suggests that residual 'microchimerism' cannot account for maintenance of tolerance. See also [58].
61. Davies JD, Leong LY, Mellor A, Cobbold SP, Waldmann H. T cell suppression in transplantation tolerance through linked recognition. of special interest J Immunol. 156:1996;3602-3607 Mice rendered tolerant to multiple minor histocompatibility antigens following treatment with nondepleting CD4 and CD8 antibodies also tolerated the presence of a 'third party' skin graft expressing an MHC class I alloantigen, providing that this test graft also expressed the same multiple minor, H antigens. This suggests that the linked recognition of 'tolerated' alloantigens with a 'nontolerated' test antigen confers nonreactivity on the T cells capable of responding to the the third party test antigen. A changed local cytokine milieu is suggested as a mechanism for this nonreactivity.
62. Madsen JC, Superina RA, Wood KJ, Morris PJ. Induction of immunological unresponsiveness using recipient cells transfected with donor MHC genes. Nature. 332:1988;161-164.
63. Saitovitch D, Morris PJ, Wood KJ. Donor-type single MHC locus products combined with anti-CD4 MAb can induce tolerance to cardiac allografts which is dependent on active suppression. Transplant Proc. 27:1995;119-120.
64. Toes REM, Blom RJJ, Offringa R, Kast WM, Melief CJM. Enhanced tumor outgrowth after peptide vaccination. of special interest J Immunol. 156:1996;3911-3918 Immunization with peptide epitopes of transplantation (tumour) antigens can lead to tolerance rather than rejection.
65. Antoniou AN, McCormick D, Scott D, Yeoman H, Chandler P, Mellor A, Dyson PJ. T cell tolerance and activation to a transgenic tumour antigen. of special interest Eur J Immunol. 26:1996;1094-1102 A similar conclusion to that of [53], namely that a CD8-specific epitope alone is not a transplantation antigen, is implied by studying the survival of skin grafts transgenic for the P91A tumor specific transplantation antigen in mice.
66. Mendoza LM, Paz P, Zuberi A, Christianson G, Roopenian D, Shastri N. Minors held by majors. The H13 minor histocompatibility locus defined as a peptide/MHC class I complex. of outstanding interest Immunity. 1997; A gene encoding the mouse H-13 histocompatibility antigen has now been identified by Mendoza and colleagues in this paper, thus providing an example of how allelic dimorphism can give rise to an autosomally-encoded minor H antigen. This is also the first example of an autososmally encoded minor H antigen being understood at both the genetic and biochemical level.